EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: implications for a mechanism for atherosclerosis protection






Metabolism: Clinical and Experimental 41(8): 827-832

Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: implications for a mechanism for atherosclerosis protection

Ethanol intake in humans has been shown to have a protective effect against coronary heart disease. The specific mechanism by which ethanol is cardioprotective has not been elucidated. Apolipoprotein (apo) A-I, the major protein of high-density lipoprotein (HDL), takes up cellular cholesterol, thus initiating reverse cholesterol transport whereby excess tissue cholesterol is eliminated. Using highly specific antibodies, we have found that ethanol increases apo A-I secretion and the incorporation of radiolabeled leucine into apo A-I by human hepatocytes (Hep-G2 cells). In addition, we have found that apo A-I molecules induced by ethanol have the ability to efflux cholesterol from human fibroblasts in vitro, and that apo A-I mass directly correlates with cholesterol efflux levels. At 10, 20, and 100 mmol/L, ethanol stimulated apo A-I secretion by 130%, 136%, and 162% of control, respectively (control, 3.71 micrograms apo A-I/micrograms DNA), also stimulating the incorporation of 3H-leucine into newly synthesized apo A-I by 115%, 131%, and 159% of control (control, 111 cpm/micrograms DNA/h). The ethanol-induced apo A-I from Hep-G2 cells (incubated with 0, 10, 20, and 100 mmol/L ethanol) effluxed 2%, 14%, 16%, and 32% label (per h/mL incubation medium), respectively. Apo A-I mass correlated linearly with cholesterol efflux (r = .99, P less than .01). This data indicates that the cardioprotective role of moderate ethanol intake in humans is mediated by its stimulatory action on hepatic apo A-I secretion, thus defining the physiological basis for increased plasma apo A-I levels in vivo.

(PDF same-day service: $19.90)

Accession: 040054715

PMID: 1640859

DOI: 10.1016/0026-0495(92)90162-4



Related references

Ethanol stimulates apolipoprotein a i secretion in human hepatocytes hep g2 cells. Clinical Research 38(2): 483A, 1990

Ethanol stimulates apo A-1 secretion in human hepatocytes: a possible mechanism underlying the cardioprotective effect of ethanol. Nutrition Reviews 51(5): 151-152, 1993

Gemfibrozil stimulates apolipoprotein AL secretion by human hepatocytes Cardioprotective mechanism implication. Clinical Research 41(1): 27A, 1993

Ethanol induces apolipoprotein a i in human hepatocytes a mechanism for coronary protection. Clinical Research 39(1): 62A, 1991

Bezafibrate, a second generation fibrate analog, stimulates transport and secretion of phosphatidylcholine in human hepatocytes by a novel mechanism of redistribution of multidrug resistance 3 p glycoprotein in the bile canaliculi. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 71, 2003

Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis. Febs Journal 281(11): 2525-2542, 2014

Ethanol stimulates production of apolipoproteins B and AI by human hepatocytes. FASEB Journal 8(4-5): A702, 1994

Ethanol stimulates bile acid formation in primary human hepatocytes. Biochemical and Biophysical Research Communications 364(4): 743-747, 2007

The effect of gemfibrozil on apolipoprotein a i secretion by human hepatocytes hep g2 cells. Clinical Research 39(2): 177A, 1991

Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism: Clinical and Experimental 40(3): 275-279, 1991